default author photo

Feray Cyrille

University of Paris-Saclay

Universite Paris Descartes - Assistance Publique - Hôpitaux de Paris

France

SCHOLARLY PAPERS

1

DOWNLOADS

53

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Everolimus and the Recurrence of Hepatocellular Carcinoma after liver transplantation: A Nationwide Emulated Target Trial Based on Real-World Data

Number of pages: 42 Posted: 26 Mar 2026
University of Paris-Saclay, University of Copenhagen - Section of Epidemiology, university Paris Saclay, University of Paris-Saclay, University of Paris-Saclay, University of Paris-Saclay, Hôpital Paul-Brousse, University of Montpellier, University of Paris - Hospital Paul Brousse and University of Paris-Saclay
Downloads 53 (1,031,043)

Abstract:

Loading...

mTOR inhibitor, Everolimus, EVR, liver transplantation, immunosuppression, HCC recurrence